Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-02-08 @ 5:52 AM
Study NCT ID:
NCT04976192
Status:
COMPLETED
Last Update Posted:
2025-10-07
First Post:
2021-07-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TV45779-IMB-30086
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |